Stifel Financial’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,250
Closed -$103K 3497
2024
Q3
$103K Sell
9,250
-3,060
-25% -$33.9K ﹤0.01% 3236
2024
Q2
$114K Sell
12,310
-8,284
-40% -$76.9K ﹤0.01% 3196
2024
Q1
$675K Buy
20,594
+11,898
+137% +$390K ﹤0.01% 2436
2023
Q4
$233K Buy
8,696
+3,240
+59% +$86.7K ﹤0.01% 2992
2023
Q3
$330K Buy
5,456
+477
+10% +$28.9K ﹤0.01% 2733
2023
Q2
$507K Buy
4,979
+1,504
+43% +$153K ﹤0.01% 2514
2023
Q1
$614K Buy
3,475
+1,170
+51% +$207K ﹤0.01% 2401
2022
Q4
$891K Sell
2,305
-175
-7% -$67.7K ﹤0.01% 2087
2022
Q3
$836K Buy
2,480
+150
+6% +$50.6K ﹤0.01% 2097
2022
Q2
$766K Sell
2,330
-39
-2% -$12.8K ﹤0.01% 2191
2022
Q1
$1.04M Buy
2,369
+723
+44% +$316K ﹤0.01% 2090
2021
Q4
$722K Sell
1,646
-791
-32% -$347K ﹤0.01% 2363
2021
Q3
$1.36M Sell
2,437
-7
-0.3% -$3.89K ﹤0.01% 1859
2021
Q2
$1.26M Sell
2,444
-70
-3% -$36K ﹤0.01% 1929
2021
Q1
$1.97M Sell
2,514
-33
-1% -$25.8K ﹤0.01% 1532
2020
Q4
$1.39M Buy
2,547
+116
+5% +$63.2K ﹤0.01% 1617
2020
Q3
$1.11M Sell
2,431
-27
-1% -$12.4K ﹤0.01% 1556
2020
Q2
$1.51M Buy
2,458
+64
+3% +$39.4K ﹤0.01% 1307
2020
Q1
$1.14M Buy
2,394
+638
+36% +$304K ﹤0.01% 1348
2019
Q4
$1.02M Buy
1,756
+290
+20% +$168K ﹤0.01% 1824
2019
Q3
$964K Buy
1,466
+132
+10% +$86.8K ﹤0.01% 1778
2019
Q2
$1.04M Buy
1,334
+404
+43% +$313K ﹤0.01% 1778
2019
Q1
$656K Sell
930
-26
-3% -$18.3K ﹤0.01% 1903
2018
Q4
$449K Buy
956
+348
+57% +$163K ﹤0.01% 1994
2018
Q3
$525K Sell
608
-17
-3% -$14.7K ﹤0.01% 2069
2018
Q2
$432K Sell
625
-156
-20% -$108K ﹤0.01% 2097
2018
Q1
$347K Sell
781
-304
-28% -$135K ﹤0.01% 2169
2017
Q4
$476K Sell
1,085
-704
-39% -$309K ﹤0.01% 1940
2017
Q3
$887K Sell
1,789
-1,310
-42% -$650K ﹤0.01% 1556
2017
Q2
$1.72M Sell
3,099
-108
-3% -$60.1K 0.01% 1170
2017
Q1
$2.12M Buy
+3,207
New +$2.12M 0.01% 1059